| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2024/02/06 | 09 : 53 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/02/01 | 14 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/02/01 | 14 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/02/01 | 14 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/02/01 | 14 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/02/01 | 14 : 15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 28 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 27 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 26 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 26 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 26 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/27 | 07 : 26 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2024/01/17 | 03 : 53 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2023/11/21 | 08 : 43 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2023/11/21 | 08 : 10 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2023/11/14 | 04 : 58 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | USOTC:NAVB | Navidea Biopharmaceuticals Inc (CE) |
| 2014/05/16 | 22 : 47 | Dow Jones News | U.S. Hot Stocks: Hot Stocks to Watch | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |
| 2014/02/18 | 23 : 18 | Dow Jones News | U.S. Hot Stocks: Hot Stocks to Watch | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |
| 2013/12/10 | 23 : 33 | Dow Jones News | U.S. Hot Stocks Futures: Hot Stocks to Watch | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |
| 2013/04/24 | 22 : 36 | Dow Jones News | Navidea Sells More Shares to J.P. Morgan's Asset Management Unit and Another Institutional Investor | AMEX:NAVB | Navidea Biopharmaceuticals Inc. |